AION — Aion Therapeutic Cashflow Statement
0.000.00%
Last trade - 00:00- CA$2.49m
- CA$5.28m
- CA$0.37m
Annual cashflow statement for Aion Therapeutic, fiscal year end - April 30th, CAD millions except per share, conversion factor applied.
2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | 2024 April 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -0.673 | -8.27 | -3.82 | -0.257 | -6.29 |
| Depreciation | |||||
| Non-Cash Items | -0.064 | 5.78 | 1.01 | -0.609 | 5.2 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 0.074 | 0.225 | 1.4 | 0.807 | 0.197 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Prepaid Expenses | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.552 | -2.13 | -1.35 | -0.041 | -0.845 |
| Capital Expenditures | -0.205 | -1.44 | — | — | — |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | -0.129 | 0.065 | 0 | 0.135 | -0.289 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.333 | -1.38 | 0 | 0.135 | -0.289 |
| Financing Cash Flow Items | 0 | 0.331 | -0.026 | 0 | 0.026 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -0.125 | 3 | 1.2 | 0.163 | 1.12 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -1.01 | -0.373 | -0.24 | 0 | 0.068 |